Jakob Haldor Topsoe - Apr 1, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director, 10%+ Owner
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Apr 1, 2022
Transactions value $
$25,000,011
Form type
4
Date filed
4/5/2022, 07:06 PM
Previous filing
Apr 4, 2022
Next filing
May 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Non-Voting Common Stock Purchase $25M +1.09M +47.89% $23.00 3.36M Apr 1, 2022 Common Stock 1.09M See footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Non-Voting Common Stock is convertible into the Issuer's Common Stock on a 1-for-1 basis (subject to a 4.99% beneficial ownership limitation that may be increased or decreased by the holder of such shares) and has no expiration date.
F2 The shares were purchased pursuant to an underwritten public offering of the Issuer's securities.
F3 The shares are held directly by Topsoe Holding A/S (formerly Haldor Topsoe Holding A/S). Jakob Haldor Topsoe, Christina Teng Topsoe, Anne Haugwitz-Hardenberg-Reventlow, Emil Oigaard, Thomas Schleicher and Birgitte Nielsen, members of the board of directors of Topsoe Holding A/S, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any.